New small molecule therapies, biologic therapies and their mechanism of action - Prof. Peter Taylor
Looking into small molecule therapies, biologic therapies and their modes of action? Tune into Professor Peter Taylor (Head of Clinical Trials and Campus Dean, Kennedy Institute of Rheumatology division, Imperial College, London, UK) who describes the up and coming biological agents in development and their potential use in joint therapy with methotrexate or as first line treatment.
